Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)

NCT02972359 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT02972359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Lead sponsor
Grünenthal GmbH
Phase
Phase 3
Overall status
Completed
Start date
December 20, 2016
Completion date
January 9, 2019
Enrollment
580 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

complex regional pain syndrome